What was studied?
The research question and design
Researchers systematically compared aging biomarkers and proposed a framework for evaluating clocks across different intended uses. Predicting chronological age, mortality risk and response to intervention are distinct validation tasks.
What researchers found
The useful signal
Different clocks capture different biological signals. A model that closely predicts calendar age is not necessarily the best predictor of mortality or another health outcome; the reported correlation between those performance measures was weak.
What this does not prove
Limitations that change the interpretation
- There is no single agreed gold standard for biological age.
- Results vary with biomarkers, population, laboratory methods and algorithm.
- A score change may reflect measurement variation or a specific input - not whole-body rejuvenation.
- Commercial reports usually do not diagnose disease or determine treatment suitability.
What this means for a consumer
Use the evidence for a better question - not a guarantee.
Choose a test according to the question you want answered. A routine blood-biomarker assessment can provide an accessible lifestyle baseline, while an epigenetic clock measures different signals. Repeat results are most meaningful when methods and conditions remain comparable.
Hallmarks connection
Biological pathways discussed
A connection to a hallmark does not demonstrate that the hallmark has been reversed or that aging has slowed.